Manjiong Wang

437 total citations
19 papers, 280 citations indexed

About

Manjiong Wang is a scholar working on Molecular Biology, Pharmacology and Infectious Diseases. According to data from OpenAlex, Manjiong Wang has authored 19 papers receiving a total of 280 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Pharmacology and 7 papers in Infectious Diseases. Recurrent topics in Manjiong Wang's work include Cholinesterase and Neurodegenerative Diseases (5 papers), HIV/AIDS drug development and treatment (4 papers) and Computational Drug Discovery Methods (3 papers). Manjiong Wang is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (5 papers), HIV/AIDS drug development and treatment (4 papers) and Computational Drug Discovery Methods (3 papers). Manjiong Wang collaborates with scholars based in China and United States. Manjiong Wang's co-authors include Jian Li, Xiaokang Li, Fei Mao, Yixiang Xu, Xinyu Zheng, Jin Zhu, Haiyan Zhang, Wei Ni, Conglong Xia and Huan Wang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Journal of Medicinal Chemistry.

In The Last Decade

Manjiong Wang

18 papers receiving 279 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manjiong Wang China 11 167 75 72 62 26 19 280
Raffaella Catalano Italy 9 149 0.9× 55 0.7× 62 0.9× 35 0.6× 24 0.9× 13 294
Xolani Henry Makhoba South Africa 7 149 0.9× 35 0.5× 62 0.9× 66 1.1× 30 1.2× 14 275
Ana L. M. Karl Brazil 5 152 0.9× 65 0.9× 63 0.9× 144 2.3× 21 0.8× 5 332
Deepika Saraswat India 10 128 0.8× 36 0.5× 116 1.6× 32 0.5× 27 1.0× 31 359
Flávia P. Dias Viegas Brazil 6 124 0.7× 79 1.1× 124 1.7× 85 1.4× 17 0.7× 9 325
Shanthi Nagarajan United States 11 206 1.2× 33 0.4× 51 0.7× 47 0.8× 30 1.2× 22 385
Siew Lee Cheong Singapore 12 189 1.1× 52 0.7× 173 2.4× 67 1.1× 39 1.5× 19 422
Alberto Ongaro Italy 11 199 1.2× 67 0.9× 98 1.4× 55 0.9× 7 0.3× 36 347
Valeria Francesconi Italy 11 85 0.5× 49 0.7× 130 1.8× 71 1.1× 19 0.7× 17 306
Abhishek Thakur United States 11 139 0.8× 26 0.3× 45 0.6× 72 1.2× 12 0.5× 24 327

Countries citing papers authored by Manjiong Wang

Since Specialization
Citations

This map shows the geographic impact of Manjiong Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manjiong Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manjiong Wang more than expected).

Fields of papers citing papers by Manjiong Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manjiong Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manjiong Wang. The network helps show where Manjiong Wang may publish in the future.

Co-authorship network of co-authors of Manjiong Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Manjiong Wang. A scholar is included among the top collaborators of Manjiong Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manjiong Wang. Manjiong Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Guo, Xiaobo, Conglong Xia, Yue Yao, et al.. (2025). Structure Optimization of Natural Product Catalpol to Obtain Novel and Potent Analogs against Heart Failure. Journal of Medicinal Chemistry. 68(4). 4540–4560. 3 indexed citations
2.
Li, Ruoxi, Zhenghui Huang, Xicheng Wang, et al.. (2024). Design, synthesis and therapeutic evaluation of novel antimalarial derivatives based on the clinical antitumor candidate drug Quisinostat. Bioorganic & Medicinal Chemistry. 115. 117985–117985.
3.
Chen, Xin, Jin Yang, Yue Yao, et al.. (2024). Novel Combination Therapy for Heart Failure: Trimebutine–Methoxsalen Identified through Synergistic Network Virtual Screening and Experimental Validation. Journal of Chemical Information and Modeling. 64(18). 7152–7162. 1 indexed citations
4.
Li, Xiao, Yue Yao, Xin Chen, et al.. (2024). Glyceraldehyde derivatives inspired by empagliflozin as potential anti-heart failure agents independent of glucose-lowering effects. SHILAP Revista de lepidopterología. 3(2). 2 indexed citations
5.
Wang, Manjiong, Zhenghui Huang, Ruoxi Li, et al.. (2022). Design and synthesis of novel hydroxamic acid derivatives based on quisinostat as promising antimalarial agents with improved safety. SHILAP Revista de lepidopterología. 1(2). 2 indexed citations
6.
Xia, Conglong, et al.. (2022). Comparative Analysis of the Chloroplast Genome for Aconitum Species: Genome Structure and Phylogenetic Relationships. Frontiers in Genetics. 13. 878182–878182. 18 indexed citations
7.
Xia, Conglong, et al.. (2022). Comparative analysis of complete chloroplast genome of ethnodrug Aconitum episcopale and insight into its phylogenetic relationships. Scientific Reports. 12(1). 9439–9439. 7 indexed citations
8.
Wang, Manjiong, Ruoxi Li, Zhenghui Huang, et al.. (2022). Drug Repurposing of Quisinostat to Discover Novel Plasmodium falciparum HDAC1 Inhibitors with Enhanced Triple-Stage Antimalarial Activity and Improved Safety. Journal of Medicinal Chemistry. 65(5). 4156–4181. 22 indexed citations
9.
Li, Ruoxi, Zhenghui Huang, Manjiong Wang, et al.. (2021). Discovery of Novel Plasmodium falciparum HDAC1 Inhibitors with Dual-Stage Antimalarial Potency and Improved Safety Based on the Clinical Anticancer Drug Candidate Quisinostat. Journal of Medicinal Chemistry. 64(4). 2254–2271. 27 indexed citations
10.
Wang, Jiqun, Jiaqi Liu, Donglei Shi, et al.. (2021). Rapid Repurposing of Novel Combination Drugs for the Treatment of Heart Failure via a Computationally Guided Network Screening Approach. Journal of Chemical Information and Modeling. 62(21). 5223–5232. 6 indexed citations
11.
Feng, Hongxuan, Hongguang Zhang, Wei Wang, et al.. (2020). Development of Novel N-hydroxypyridone Derivatives as Potential Anti-Ischemic Stroke Agents. Journal of Medicinal Chemistry. 63(3). 1051–1067. 18 indexed citations
12.
Wang, Manjiong, Yixiang Xu, Zengrui Wu, et al.. (2020). Drug repositioning by prediction of drug’s anatomical therapeutic chemical code via network-based inference approaches. Briefings in Bioinformatics. 22(2). 2058–2072. 34 indexed citations
13.
Li, Ruoxi, Zhenghui Huang, Manjiong Wang, et al.. (2020). Repurposing of antitumor drug candidate Quisinostat lead to novel spirocyclic antimalarial agents. Chinese Chemical Letters. 32(5). 1660–1664. 10 indexed citations
14.
Ni, Wei, Huan Wang, Xiaokang Li, et al.. (2018). Novel Tadalafil Derivatives Ameliorates Scopolamine-Induced Cognitive Impairment in Mice via Inhibition of Acetylcholinesterase (AChE) and Phosphodiesterase 5 (PDE5). ACS Chemical Neuroscience. 9(7). 1625–1636. 22 indexed citations
15.
Ni, Shuaishuai, Baoli Li, Feifei Chen, et al.. (2018). Novel Staphyloxanthin Inhibitors with Improved Potency against Multidrug Resistant Staphylococcus aureus. ACS Medicinal Chemistry Letters. 9(3). 233–237. 10 indexed citations
16.
Mao, Fei, Shuaishuai Ni, Feifei Chen, et al.. (2017). Discovery of novel piperonyl derivatives as diapophytoene desaturase inhibitors for the treatment of methicillin-, vancomycin- and linezolid-resistant Staphylococcus aureus infections. European Journal of Medicinal Chemistry. 145. 235–251. 11 indexed citations
17.
18.
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Raffaella Catalano Breakdown of academic impact, for papers by Xolani Henry Makhoba Breakdown of academic impact, for papers by Ana L. M. Karl Breakdown of academic impact, for papers by Deepika Saraswat Breakdown of academic impact, for papers by Flávia P. Dias Viegas Breakdown of academic impact, for papers by Shanthi Nagarajan Breakdown of academic impact, for papers by Siew Lee Cheong Breakdown of academic impact, for papers by Alberto Ongaro Breakdown of academic impact, for papers by Valeria Francesconi Breakdown of academic impact, for papers by Abhishek Thakur
Rankless by CCL
2026